Herbal guide
Herbs

Gynostemma Pentaphyllum

Gynostemma pentaphyllum (jiaogulan) is a climbing herb used traditionally in East Asia for metabolic and cardiovascular health. Modern research focuses on its saponin-rich extracts (gypenosides) and documented effects on lipids, glucose regulation, and antioxidant pathways in preclinical models, with limited but suggestive human trial data.

Immortality herb
Jiaogulan
Southern ginseng
Xiancao

This guide covers all common forms and variations of gynostemma pentaphyllum in one place. Use the sections below to find the form that fits your situation.

How it works in the body

Gypenosides, the primary saponin constituents of Gynostemma pentaphyllum, activate AMP-activated protein kinase (AMPK) in cell and animal studies. AMPK is a central energy-sensing kinase that regulates glucose uptake, fatty acid oxidation, and hepatic lipid synthesis; its activation is one proposed mechanism behind the observed improvements in glucose metabolism and reductions in hepatic steatosis seen in preclinical models.

Additional mechanisms include upregulation of endogenous antioxidant enzymes (superoxide dismutase, catalase) and reduction of pro-inflammatory cytokines in animal and in vitro studies. Flavonoids and polysaccharides in the herb likely contribute to immunomodulatory and hepatoprotective effects. Human mechanistic data are sparse, so the clinical translation of these pathways requires further investigation.

Body systems

Metabolic function
Cardiovascular system
Liver function
Immune/inflammatory response

Associated molecules

Gypenosides (dammarane-type saponins)
Flavonoids
Polysaccharides

Track it lightly

If you're considering Gynostemma pentaphyllum, record baseline labs (glucose, lipids) and symptoms before starting, begin at a low dose, and reassess after 4–12 weeks to evaluate whether measurable changes occur.

Trying this? Start tracking it here.

Background

Gynostemma pentaphyllum is a climbing vine native to southern China and parts of Southeast Asia. It has been used in traditional Chinese and folk medicine as a longevity tonic and for cardiovascular and metabolic complaints. Scientific interest intensified after researchers isolated gypenosides — saponins structurally similar to ginsenosides — and began examining their effects on lipid metabolism, glucose regulation, and oxidative stress in the late 20th century. Despite promising preclinical data, large, well-controlled human trials remain scarce.

Evidence snapshot

Preclinical studies show that gypenosides — dammarane-type saponins from Gynostemma pentaphyllum — modulate metabolic pathways including AMP-activated protein kinase (AMPK), reduce oxidative stress markers, and attenuate inflammatory signaling in cell and animal models. Mechanistic work supports effects on hepatic lipid metabolism, insulin signaling, and antioxidant enzyme expression.

Human data consist of small randomized and open-label trials plus observational studies reporting modest improvements in lipid profiles, fasting glucose, and oxidative stress markers. Trial sizes, extract standardization, and study durations vary widely; clinical certainty is low-to-moderate, and larger high-quality randomized trials are needed before firm efficacy conclusions can be drawn.

Short-term safety data are generally reassuring at common doses (tea or standardized extract), with adverse effects uncommon and mild (digestive upset, headache). Interactions and long-term safety are understudied; caution is warranted with antiplatelet, anticoagulant, or glucose-lowering medications.

Bioavailability and formulations

Gypenosides are saponins with variable oral absorption; bioavailability depends on extract type and formulation. Hot-water infusion (tea) yields a broad mix of water-soluble saponins, flavonoids, and polysaccharides. Standardized ethanol or mixed-solvent extracts concentrate gypenosides and are the form most commonly used in clinical studies to achieve consistent dosing. Pharmacokinetic data in humans are sparse, and head-to-head comparisons of bioavailability across formulations have not been published.

Populations studied

Most human research has involved adults with metabolic concerns (hyperlipidemia, metabolic syndrome) or generally healthy volunteers. Sample sizes are typically small, and studies vary in extract standardization and duration. Evidence in pediatric, pregnant, or severely ill populations is absent; avoid use in these groups unless under direct medical supervision.

Long-term safety

Short-term studies (weeks to a few months) report few serious adverse events, with mild digestive complaints most commonly noted. Continuous long-term use has not been formally evaluated. Because gypenosides influence glucose metabolism and potentially affect platelet function, people on hypoglycemic or anticoagulant therapy should seek medical monitoring before committing to prolonged use.

Standardization and quality control

Product heterogeneity is a significant practical issue — commercial products vary considerably in gypenoside content and extraction method. When possible, select products that disclose total saponin or gypenoside content, carry third-party testing certification for contaminants (heavy metals, pesticides), and are manufactured under GMP conditions. Label transparency is essential for interpreting dosing relative to published clinical data.

Compound variations

Jiaogulan (whole-leaf tea)

Gynostemma Pentaphyllum

Traditional infusion of dried Gynostemma leaves containing a broad mix of saponins, flavonoids, and polysaccharides.

Common use case

Users who prefer whole-herb preparations for general wellness.

Dosage note

Typical dose: 2–6 g dried leaf infused as tea daily in divided doses.

Standardized gypenoside extract

Gynostemma Pentaphyllum

Concentrated extract standardized to total saponin or gypenoside content for consistent dosing.

Common use case

Users seeking reproducible, measurable dosing aligned with clinical study protocols.

Dosage note

Common study doses: 100–400 mg/day depending on saponin concentration.

Gypenoside-enriched fraction

Gynostemma Pentaphyllum

Fractionated preparations enriched for specific gypenosides, primarily used in mechanistic research.

Common use case

Research settings or supervised therapeutic exploration.

Dosage note

Dosing varies widely; follow product labeling or study protocol.

Fermented jiaogulan

Gynostemma Pentaphyllum

Fermented forms aim to alter bioavailability and flavor; active constituent levels may differ from tea or standardized extracts.

Common use case

Users seeking alternative taste profiles or potentially altered metabolite composition.

Dosage note

Follow product-specific guidance; no clinical dosing standards exist for fermented forms.

Dosage and best practices

Dosage principles

  • Traditional tea: 2–6 g of dried leaf per day as an infusion in divided doses — the form used in observational human studies and traditional practice.
  • Standardized extract: 100–400 mg/day of a gypenoside-containing extract (standardized to saponin content), taken once or twice daily, as used in clinical trials reporting metabolic effects.
  • Most human studies last 4–12 weeks; longer-term safety and efficacy data are limited and warrant clinician monitoring.

Best practices

  • Prefer standardized extracts with stated gypenoside or total saponin content when reproducible dosing is the goal.
  • Start at the lower end of the dose range (100 mg/day standardized extract or 1–2 g/day dried leaf tea) and monitor blood glucose and lipids if using for metabolic indications.
  • Do not self-adjust prescription diabetes or anticoagulant medications; consult a clinician before combining Gynostemma with these drugs.

Literature and references

Common questions

Is jiaogulan the same as ginseng?

No. Although called 'southern ginseng' because some gypenosides resemble ginsenosides structurally, Gynostemma pentaphyllum is a distinct species with different phytochemistry and traditional uses. It is not a substitute for Panax ginseng.

Will it lower my cholesterol or blood sugar?

Small trials suggest modest improvements in lipids and glucose in some participants, but the evidence is inconsistent and limited by small study sizes and variable preparations. It should not replace prescribed treatments without clinician oversight.

How should I take it — tea or extract?

Both forms are used. Tea (2–6 g dried leaf/day) is the traditional approach, while standardized extracts (100–400 mg/day of gypenoside-containing extract) allow more consistent dosing. Choose based on your goals, product quality, and whether reproducible dosing matters.

Are there any major drug interactions?

Clinically documented interactions are limited. Additive effects with glucose-lowering medications and possible effects on coagulation are the primary concerns based on preclinical data. Consult your clinician if you take prescription diabetes medications or anticoagulants.

Is it safe during pregnancy or breastfeeding?

There are no adequate safety data for pregnancy or lactation. Avoid use during pregnancy and breastfeeding unless specifically directed by a healthcare provider.

Related guides